Disclosure Of Fair Value Measurement [Text Block]

Xbrane Biopharma - Filing #702449

Concept	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31
Disclosure of fair value measurement [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of assets [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets	—	688 427 SEK	—	—	—	—	—	—	—	463 763 SEK	—	—	—	—	—	—	—	—	—	—
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of liabilities [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of liabilities [abstract]
Disclosure of fair value measurement of liabilities [line items]
Liabilities	—	256 686 SEK	—	—	—	—	—	—	—	206 055 SEK	—	—	—	—	—	—	—	—	—	—
Reconciliation of changes in fair value measurement, liabilities [abstract]
Disclosure of fair value measurement of equity [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity	713 313 SEK	431 741 SEK	5 165 SEK	1 134 276 SEK	5 614 SEK	524 938 SEK	4 977 SEK	3 945 SEK	773 724 SEK	257 708 SEK	184 323 SEK	3 456 SEK	6 719 SEK	448 089 SEK	159 352 SEK	6 719 SEK	298 912 SEK	3 456 SEK	448 089 SEK	273 941 SEK
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]